Testing effectiveness (Phase 2)Study completedNCT02711826
What this trial is testing
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Who this might be right for
Kidney TransplantAdult Living Donor Kidney Transplant RecipientsRenal Transplant+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 32